Bcl-2 is a highly significant prognostic marker of hormone-receptor-positive, human epidermal growth factor receptor-2-negative breast cancer

Molecular portraits of human breast tumours

Charles M. Perou, Thérese Sørlie, Michael B. Eisen et al. · Nature · 2000 · 16.3K citations

Medicine, Molecular Biology, Oncology +14

Gene expression profiling predicts clinical outcome of breast cancer

Laura van ‘t Veer, Hongyue Dai, Marc J. van de Vijver et al. · Nature · 2002 · 9.6K citations · Full text

Life Sciences, Molecular Biology, Oncology +16

Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer Study

Lisa A. Carey, Charles M. Perou, Chad Livasy et al. · JAMA · 2006 · 3.8K citations

Medicine, Biostatistics, Oncology +14

Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases

Christine L. Carter, Carol Allen, Donald E. Henson · Cancer · 1989 · 2.3K citations · Full text

Medicine, Oncology, Surgery +16

Prognostic Value of a Combined Estrogen Receptor, Progesterone Receptor, Ki-67, and Human Epidermal Growth Factor Receptor 2 Immunohistochemical Score and Comparison With the Genomic Health Recurrence Score in Early Breast Cancer

Jack Cuzick, Mitch Dowsett, Sílvia Pineda et al. · Journal of Clinical Oncology · 2011 · 744 citations

Medicine, Cancer Biology, Oncology +16